Inclusion criteria | Exclusion criteria |
---|---|
> 18 years of age | Life-threatening or limb-threatening condition requiring immediate management |
Acute moderate to severe pain (both medical and traumatic etiology) defined by self-reporting pain ≥ 4 on numeric rating scale | Pregnancy or breastfeeding |
Capable of giving informed consent | Know allergies, hypersensitivity, or serious side effects to opioids or methoxyflurane or other excipients |
Normal physiology | Head injury or medical conditions with neurological impairment (Glasgow coma scale < 14) |
Previous malignant hyperthermia or persons with suspect genetic predisposition for malignant hyperthermia | |
Massive facial trauma, visible nasal blockage, or on-going nose bleeding | |
History of severe liver disease with jaundice and scleral icterus | |
Dialysis or history of severe renal disease (known chronic kidney failure stage 4 or 5) | |
Monoaminoxidase inhibitors last 14 days (pharmacological treatment of depression, Morbus Parkinson or narcolepsy) | |
Myasthenia gravis | |
Use of investigational medicinal product analgesics 12 h prior to inclusion | |
Any condition that in the view of the study worker would suggest that the patient is unable to comply with study protocol and procedures |